Nanotechnology Applied to Pharmaceutical Chemistry
DOI:
https://doi.org/10.61164/hv1ceb36Keywords:
Nanotechnology; Pharmaceutical Chemistry; Nanoparticles; Innovation.Abstract
Nanotechnology is a rapidly expanding science that has profoundly changed the course of the pharmaceutical and medicinal chemistry industries. By operating at the nanoscale, it is possible to control the physicochemical properties of materials, favoring the bioavailability, selectivity, and efficacy of drugs. This article aims to discuss the main applications of nanotechnology in pharmaceutical chemistry, addressing controlled-release systems, advanced diagnostics, and new pharmacological formulations. The research was conducted through a literature review in national and international scientific databases. It was found that nanotechnology provides significant gains in cancer treatments, infectious diseases, and vaccines, but still faces challenges regarding toxicity, stability, and regulation. Furthermore, it is observed that the development of nanosystems opens avenues for personalized medicine, allowing for safer, more effective, and innovative therapies capable of profoundly transforming the future of pharmacotherapy.
Downloads
References
ALLEN, T. M.; CULLIS, P. R. Liposomal drug delivery systems: From concept to clinical applications. Advanced Drug Delivery Reviews, v. 65, n. 1, p. 36-48, 2013. DOI: https://doi.org/10.1016/j.addr.2012.09.037
ANVISA. Relatório de Nanotecnologia e Regulação no Brasil. Brasília: ANVISA, 2022.
BHUSHAN, B. Springer Handbook of Nanotechnology. 4. ed. Berlin: Springer, 2017. DOI: https://doi.org/10.1007/978-3-662-54357-3
FERRARI, M. Cancer nanotechnology: Opportunities and challenges. Nature Reviews Cancer, v. 5, n. 3, p. 161-171, 2005. DOI: https://doi.org/10.1038/nrc1566
FERREIRA, L. S. et al. Nanotecnologia e indústria farmacêutica: tendências e perspectivas. Revista Brasileira de Ciências Farmacêuticas, v. 57, n. 2, p. 88-96, 2021.
FONSECA, C. et al. Polymeric nanoparticles for drug delivery: Current developments and future directions. Journal of Biomedical Nanotechnology, v. 14, n. 1, p. 1-19, 2018.
JIANG, W. et al. Nanoparticle-mediated cellular responses: Implications for cancer therapy. Nano Today, v. 35, p. 100937, 2020. DOI: https://doi.org/10.1016/j.nantod.2020.100946
KRAMMER, F. SARS-CoV-2 vaccines in development. Nature, v. 586, n. 7830, p. 516-527, 2020. DOI: https://doi.org/10.1038/s41586-020-2798-3
LAMMERS, T. et al. Nanomedicine for precision medicine: Current state and future perspectives. ACS Nano, v. 14, n. 2, p. 1312-1341, 2020.
PEER, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, v. 2, p. 751-760, 2007. DOI: https://doi.org/10.1038/nnano.2007.387
8
SANTOS, D. S. et al. Nanotechnology-based drug delivery systems against infectious diseases. Journal of Controlled Release, v. 322, p. 303-316, 2020.
SAHOO, S. K.; LABHASETWAR, V. Nanotech approaches to drug delivery and imaging. Drug Discovery Today, v. 8, n. 24, p. 1112-1120, 2003. DOI: https://doi.org/10.1016/S1359-6446(03)02903-9
SILVA, A. C.; LIMA, B. S. Desafios na biodisponibilidade de fármacos e alternativas nanotecnológicas. Revista Brasileira de Farmácia Hospitalar, v. 9, n. 2, p. 44-51, 2018.
TEWARI, R. et al. Dendrimers in drug delivery: A review of current progress. International Journal of Pharmaceutics, v. 548, n. 1, p. 707-720, 2018. DOI: https://doi.org/10.1016/j.ijpharm.2018.07.030
WORLD HEALTH ORGANIZATION (WHO). Global report on nanotechnology and health. Geneva: WHO, 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Geraldo Henrique Kloss de Mello, Júlia Silva Freire, Matheus Carvalho dos Santos, Willemberg Nicolai
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
